Skip to main navigation Skip to search Skip to main content

Discovery of non-zwitterionic aryl sulfonamides as Nav1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation

  • Yong Jin Wu
  • , Jason Guernon
  • , Andrea McClure
  • , Guanglin Luo
  • , Ramkumar Rajamani
  • , Alicia Ng
  • , Amy Easton
  • , Amy Newton
  • , Clotilde Bourin
  • , Dawn Parker
  • , Kathleen Mosure
  • , Omar Barnaby
  • , Matthew G. Soars
  • , Ronald J. Knox
  • , Michele Matchett
  • , Rick Pieschl
  • , James Herrington
  • , Ping Chen
  • , D. V. Sivarao
  • , Linda J. Bristow
  • Nicholas A. Meanwell, Joanne Bronson, Richard Olson, Lorin A. Thompson, Carolyn Dzierba
  • Bristol-Myers Squibb

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)5490-5505
Number of pages16
JournalBioorganic and Medicinal Chemistry
Volume25
Issue number20
DOIs
StatePublished - 2017

ASJC Scopus Subject Areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Keywords

  • Benzenesulfonamide
  • Membrane permeability
  • Na1.7 inhibitor
  • Neuropathic and inflammatory pain
  • Nociceptive flexion reflex (NFR)
  • Translational electromyogram

Cite this